Oxaliplatin 100mg/50mL Injection

Oxaliplatin 100mg/50mL is a platinum chemotherapy used with fluorouracil and leucovorin for colorectal cancer. It is used in advanced disease and after surgery for stage III colon cancer to reduce the risk of recurrence.
A chemotherapy nurse administers the diluted medicine through an intravenous infusion, commonly over two hours as part of a scheduled cycle. The dose is calculated from body size and adjusted for blood results, kidney function and nerve symptoms. It is not an intramuscular injection.
Oxaliplatin forms platinum links within DNA. This damages the genetic instructions cancer cells need to copy themselves and interferes with cell division.
Numbness or tingling, cold sensitivity, nausea, vomiting, diarrhoea, mouth sores, tiredness and low blood-cell counts are common. Severe allergy can occur during any cycle. Breathlessness, facial swelling, fever or unusual bleeding needs urgent attention.
Cold drinks, cold objects and cold air can trigger nerve symptoms; avoid these exposures for five days after each infusion. Report difficulty fastening buttons, walking or handling small objects because cumulative neuropathy can require a dose change. Blood counts and renal function are checked before cycles.
In combination treatment, oxaliplatin can improve control of advanced colorectal cancer. After appropriate surgery, it can reduce the chance of recurrence by treating cancer cells too small to detect on scans.
Oxaliplatin can temporarily make sensory nerves unusually sensitive to cold, including nerves in the mouth and throat. Use room-temperature drinks; new breathing difficulty still needs immediate assessment.
Short-lived cold-triggered tingling can settle between cycles. Symptoms lasting into the next cycle or affecting daily tasks suggest cumulative neuropathy and should be reported before the next infusion.
No. Although both contain platinum, they have different cancer regimens, preparation requirements and adverse-effect patterns. Their milligram doses are not interchangeable.
Yes. Previous tolerance does not rule out a later reaction. Flushing, itching, throat tightness or faintness during infusion should be reported to the nurse immediately.
Platinum chemotherapy: anticancer treatment forming DNA-damaging platinum complexes. Adjuvant therapy: treatment after primary surgery. Neuropathy: injury or disturbance of peripheral nerves. Intravenous infusion: medicine delivered gradually into a vein. Neutropenia: reduced infection-fighting white cells.; AR: Oxaliplatin 100mg/50mL حقن; FR: Oxaliplatin 100mg/50mL préparation injectable; PT: Oxaliplatin 100mg/50mL injetável; ES: Oxaliplatin 100mg/50mL inyectable; RU: Oxaliplatin 100mg/50mL инъекционная форма; ID: Oxaliplatin 100mg/50mL injeksi; VI: Oxaliplatin 100mg/50mL thuốc tiêm; MS: Oxaliplatin 100mg/50mL suntikan; TL: Oxaliplatin 100mg/50mL iniksyon; ZH-SG: Oxaliplatin 100mg/50mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Oxaliplatin 100mg/50mL Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Oxaliplatin 100mg/50mL Injection